The appreciation that BAFF overexpression induced in murine models causes SLE and that BAFF inhibition delays SLE onset has encouraged the development of therapeutic agents for inhibiting BAFF, APRIL, or their receptors, as treatments for SLE and other autoimmune disorders [56]. The gene discussed is TNFSF13B; the disease is autoimmune disease.